Institutional & Insider Ownership
22.2% of Applied DNA Sciences shares are held by institutional investors. 36.4% of Data443 Risk Mitigation shares are held by company insiders. Comparatively, 0.0% of Applied DNA Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Profitability
This table compares Data443 Risk Mitigation and Applied DNA Sciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Data443 Risk Mitigation | -113.40% | N/A | -83.69% |
| Applied DNA Sciences | -194.14% | -66.95% | -50.34% |
Valuation and Earnings
This table compares Data443 Risk Mitigation and Applied DNA Sciences”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Data443 Risk Mitigation | $4.87 million | 0.03 | -$6.09 million | N/A | N/A |
| Applied DNA Sciences | $3.43 million | 0.62 | -$6.99 million | ($537.48) | -0.01 |
Data443 Risk Mitigation has higher revenue and earnings than Applied DNA Sciences.
Risk & Volatility
Data443 Risk Mitigation has a beta of 40.53, suggesting that its stock price is 3,953% more volatile than the S&P 500. Comparatively, Applied DNA Sciences has a beta of 0.07, suggesting that its stock price is 93% less volatile than the S&P 500.
Summary
Data443 Risk Mitigation beats Applied DNA Sciences on 6 of the 9 factors compared between the two stocks.
About Data443 Risk Mitigation
Data443 Risk Mitigation, Inc. provides data security and privacy management solutions in the United States. The company offers Cyren Threat Intelligence Service that provides security, response, software, and services; Cyren Inbox Security for Microsoft 365, which prevents user access to malicious links and attachments; Ransomware Recovery Manager to recover a workstation upon infection to the last known business-operable state; Data Identification Manager, a data classification and governance technology; Data Archive Manager for enterprise data retention management and archiving; and Sensitive Content Manager, a cloud-based platform for managing, protecting, and distributing digital content. It also provides Data Placement Manager, a data transport, transformation, and delivery product; Access Control Manager that enables access controls across various platforms at scale for internal client systems and commercial public cloud platforms; Blockchain Protection Manager, which protects blockchain transactions from inadvertent disclosure and data leaks; and Global Privacy Manager, a privacy compliance and consumer loss mitigation platform. In addition, the company offers IntellyWP to enhance the user experience for content management platform; Chat History Scanner, which scans chat messages for compliance, security, personally identifiable information, personal information, payment card industry information, and custom keywords; and GDPR Framework, CCPA Framework, and LGPD Framework WordPress Plugins that enables organizations’ compliance on privacy rules and regulations. It serves the government, financial services, healthcare, manufacturing, retail, technology, and telecommunications sectors. The company was formerly known as LandStar, Inc. and changed its name to Data443 Risk Mitigation, Inc. in October 2019. Data443 Risk Mitigation, Inc. was founded in 1998 and is headquartered in Research Triangle Park, North Carolina.
About Applied DNA Sciences
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Receive News & Ratings for Data443 Risk Mitigation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Data443 Risk Mitigation and related companies with MarketBeat.com's FREE daily email newsletter.
